Biomarkers of Exposure for Cigarette Smoke |
Park, Chul-Hoon
(KT&G Central Research Institute)
Shin, Han-Jae (KT&G Central Research Institute) Lee, Hyeong-Seok (KT&G Central Research Institute) Yoo, Ji-Hye (KT&G Central Research Institute) Sohn, Hyung-Ok (KT&G Central Research Institute) |
1 | Athersuch, T. J., Keun, H., Tang, H. and Nicholson, J. K. (2006) Quantitative urinalysis of the mercapturic acid conjugates of allyl formate using high-resolution NMR spectroscopy. J Pharm Biomed Anal. 40(2): 410-416 DOI PUBMED ScienceOn |
2 | Byrd, G. D., Davis, R. A. and Ogden, M. W. (2005) A rapid LC-MS-MS method for the determination of nicotine and cotinine in serum and saliva samples from smokers: validation and comparison with a radioimmunoassay method. J Chromatogr Sci. 43(3): 133-140 DOI ScienceOn |
3 | Byrd, G. D. and Ogden, M. W. (2003) Liquid chromatographic/tandem mass spectrometric method for the determination of the tobacco-specific nitrosamine metabolite NNAL in smokers' urine. J Mass Spectrom. 38(1): 98-107 DOI ScienceOn |
4 | Institute of Medicine, Committee on Quality of Health Care in America (2001). Crossing the quality chasm: A new health care system for the 21st century. National Academy Press, Washington, DC, USA |
5 | International Agency for Research on Cancer. (2004). Tobacco smoke and involuntary smoking. In, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. (Vol. 83). Lyon, France |
6 | Kaye, C. M. (1973) Biosynthesis of mercapturic acids from allyl alcohol, allyl esters and acrolein. Biochem J. 134(4): 1093-1101 DOI |
7 | McDonald, J. D., Bechtold, W. E., Krone, JR., Blackwell, W. B., Kracko, D. A. and Henderson, R. F. (2004) Analysis of butadiene urinary metabolites by liquid chromatography-triple quadrupole mass spectrometry. J Anal Toxicol. 28(3): 168-173 DOI ScienceOn |
8 | Sapkota, A., Halden, R. U., Dominici, F., Groopman, J. D. and Buckley, T. J. (2006) Urinary biomarkers of 1,3-butadiene in environmental settings using liquid chromatography isotope dilution tandem mass spectrometry. Chem Biol Interact. 160(1):70-79 DOI ScienceOn |
9 | Scherer, G., Urban, M., Engl, J., Hagedorn, H. W. and Riedel, K. (2006) Influence of smoking charcoal filter tipped cigarettes on various biomarkers of exposure. Inhal Toxicol. 18(10): 821-829 DOI ScienceOn |
10 | Shields, P. G. (2002) Tobacco smoking, harm reduction, and biomarkers. J Natl Cancer Inst. 94(19): 1435-1444 DOI ScienceOn |
11 | Stevens, J. F. and Maier, C. S. (2008) Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol Nutr Food Res. 52(1): 7-25 DOI ScienceOn |
12 | Degiampietro, P., Peheim, E., Drew, D., Graf, H. and Colombo, J. P. (1987) Determination of thiocyanate in plasma and saliva without deproteinisation and its validation as a smoking parameter. J Clin Chem Clin Biochem. 25(10): 711-717 |
13 | Jacob, P. 3rd,, Yu, L., Shulgin, A. T. and Benowitz, N. L. (1999) Minor tobacco alkaloids as biomarkers for tobacco use: comparison of users of cigarettes, smokeless tobacco, cigars, and pipes. Am J Public Health. 89(5): 731-736 DOI ScienceOn |
14 | Bowman, D. L., Smith, C. J., Bombick, B. R. and Avalos, J. T., Davis, R. A., Morgan, W. T. and Doolittle, D. J. (2002) Relationship between FTC 'tar' and urine mutagenicity in smokers of tobacco-burning or Eclipse cigarettes. Mutat Res. 521(1-2): 137-149 DOI ScienceOn |
15 | Urban, M., Gilch, G., Schepers, G., van Miert, E. and Scherer, G. (2003) Determination of the major mercapturic acids of 1,3-butadiene in human and rat urine using liquid chromatography with tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 796(1): 131-140 DOI ScienceOn |
16 | SRNT Subcommittee on Biochemical Verification. (2002) Biochemical verification of tobacco use and cessation. Nicotine Tob Res. 4(2): 149-159 DOI ScienceOn |
17 | Carmella, S. G., Akerkar, S. A., Richie, J. P. and Jr, Hecht, S. S. (1995) Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone (NNK) in smokers' urine. Cancer Epidemiol Biomarkers Prev. 4(6): 635-642 |
18 | Hecht, S. S., Carmella, S. G., Murphy, S. E., Akerkar, S., Brunnemann, K. D. and Hoffmann, D. (1993) A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. N Engl J Med. 329(21): 1543-1546 DOI ScienceOn |
19 | International Agency for Research on Cancer (2007) Smokeless tobacco and tobacco-specific nitrosamines. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 89. Lyon (France): IARC; 2007. p. 553 |
20 | Scherer, G., Engl, J., Urban, M., Gilch, G., Janket, D. and Riedel, K. (2007) Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany. Regul. Toxicol. Pharmacol. 47(2); 171-183 DOI ScienceOn |
21 | Life Science Research Office (2007) Scientific methods to evaluate potential reduced-risk tobacco product, 1st ed. p.49-56, Catherine ed., Life Science Research Office, Maryland, USA |
22 | Sepkovic, D. W. and Haley, N. J. (1985) Biomedical applications of cotinine quantitation in smoking related research. Am J Public Health. 75(6): 663-665 DOI ScienceOn |
23 | Muscat, J. E., Djordjevic, M. V., Colosimo, S., Stellman, S. D., and Richie, J. P. Jr. (2005) Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan one (NNK). Cancer. 103(7): 1420-1426 DOI ScienceOn |
24 | Tricker, A. R. (2006) Biomarkers derived from nicotine and its metabolites: a review, Beitr. Tabakforsch. Int. 22: 147–175 |
25 | Hecht, S. S. (1999) DNA adduct formation from tobacco-specific N-nitrosamines. Mutat Res. 424(1-2): 127-142 DOI PUBMED ScienceOn |
26 | Roethig, H. J., Kinser, R. D., Lau, R. W., Walk, R. A. and Wang, N. (2005) Short-term exposure evaluation of adult smokers switching from conventional to first-generation electrically heated cigarettes during controlled smoking. J Clin Pharmacol. 45(2): 133-145 DOI ScienceOn |
27 | Hatsukami, D. K., Benowitz, N. L., Rennard, S. I., Oncken, C. and Hecht, S. S. (2006) Biomarkers to assess the utility of potential reduced exposure tobacco products. Nicotine Tob Res. 8(4): 600-622 |
28 | Carmella, S. G., Akerkar, S. and Hecht, S. S. (1993) Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan one in smokers' urine. Cancer Res. 53(4): 721-724 |
29 | Boeniger, M. F., Lowry, L. K, and Rosenberg, J. (1993) Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: a review. Am Ind Hyg Assoc J. 54(10): 615-627 DOI ScienceOn |
30 | Sturla, S. J., Scott, J., Lao, Y., Hecht, S. S. and Villalta, P. W. (2005) Mass spectrometric analysis of relative levels of pyridyloxobutylation adducts formed in the reaction of DNA with a chemically activated form of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan one. Chem Res Toxicol. 18(6): 1048-1055 DOI ScienceOn |